Selected Start-Ups Founded in 1999 (2/99)
Out of the Blocks summarizes the technologies of recent start-ups Cytokinetics Inc., IntraVec Inc., Mycota, Nicogen Inc., Proliance Pharmaceuticals Inc. and Therus Corp.
You may also be interested in...
The European Medicines Agency commits to exploring real-world data as part of its new Regulatory Science Strategy to 2025.
Amgen’s burgeoning biosimilar presence continues to grow apace and now the company has eyes firmly on the US market for eculizumab after brokering a deal with originator Alexion. The biosimilars developer chose to settle on three of Alexion’s patents ahead of a trial later this year.